Drawspaz 250mg/80mg Tablet
Marketer
Welbe Life Sciences
Salt Composition
Drotaverine (250mg) + Mefenamic Acid (80mg)
Overview Drawspaz 250mg/80mg Tablet
Abdominal pain relief is provided by the combined medication, Alievex 250mg/80mg Tablet. This formulation effectively alleviates abdominal pain, distension, discomfort, and spasms by inducing relaxation of the stomach and intestinal muscles. It simultaneously inhibits specific pain-inducing neurotransmitters. Alievex 250mg/80mg Tablets should be taken with meals, following your physician's prescribed dosage and duration. Dosage is tailored to your individual response and condition. Continue the medication as directed; premature cessation may lead to symptom recurrence and potential worsening of your condition. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite suppression, thirst, and heartburn. Most side effects are transient and self-limiting. Report any concerning side effects to your doctor immediately. Dizziness and somnolence may occur; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to potential exacerbation of dizziness. Consult your doctor prior to use if you are pregnant, planning pregnancy, breastfeeding, or have kidney or liver disease, to ensure appropriate dosage.
Primary Ingredients of Drawspaz 250mg/80mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Drawspaz 250mg/80mg Tablet
Managing abdominal discomfort
Major Benefits of Drawspaz 250mg/80mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Drawspaz 250mg/80mg tablets should be administered with a meal.
Common Side effects of Drawspaz 250mg/80mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Drawspaz 250mg/80mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the Drawspaz 250mg/80mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Drawspaz 250mg/80mg Tablet works:
Combiflam-D 250mg/80mg tablets combine Drotaverine, a muscle relaxant easing abdominal spasms, with Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID). This dual action targets both the cramping and inflammation causing abdominal discomfort. Mefenamic Acid reduces pain by inhibiting inflammatory mediators, while Drotaverine specifically addresses smooth muscle contractions.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Drawspaz 250mg/80mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Drawspaz 250mg/80mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against the risks before recommending its use. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Drawspaz 250mg/80mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Drawspaz 250mg/80mg tablets might lead to adverse reactions that impair driving ability, as dizziness is a potential side effect.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Drawspaz 250mg/80mg tablets, as dose modification may be necessary. Consult your physician for guidance. Drawspaz 250mg/80mg tablets are contraindicated in patients with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Drawspaz 250mg/80mg tablets cautiously. Dosage modification may be necessary for these patients. Physician consultation is advised.
What if you forget to take Drawspaz 250mg/80mg Tablet :
Should you forget a Drawspaz 250mg/80mg Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Drawspaz 250mg/80mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently